Radiopharm Theranostics RADX
NASDAQ RADX
$1.44 -0.18 (-11.11%)
As of: Oct 1, 2026 · 10:36 AM EDT

Radiopharm Theranostics (RADX) Share-based Compensation (2023 - 2026)

Updated

Radiopharm Theranostics (RADX) reported Share-based Compensation of -$16,340 for FY2026 (year ended Jun 30, 2026), compared with -$1.9 million in FY2025.

Analysis

Radiopharm Theranostics (RADX) Share-based Compensation (2023 - 2026) Analysis & Trends

Dating back to FY2023, Radiopharm Theranostics' Share-based Compensation record includes 4 fiscal years.

  • According to Business Quant data, Share-based Compensation came in at -$1.9 million in FY2025, -$2.64 million in FY2024 and -$3.04 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 458.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 166.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 231.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 170.20 Mn
10 Radiopharm Theranostics 5.74 Bn 5.70 Bn 186,835.86 -1.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.71 Mn
Jun 30, 2025 -1.90 Mn
Jun 30, 2024 -2.64 Mn
Jun 30, 2023 -3.04 Mn
API Access

Radiopharm Theranostics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RADX&period=max&api_key=YOUR_API_KEY